J&J issues device recall
Johnson & Johnson said it has recalled two lots of Simponi injection devices - one in the United States and one in Europe - after discovering they may deliver less than a full dose of the rheumatoid arthritis medicine.
The potential defect was discovered by the company during regular quality testing and the voluntary recall was initiated earlier this week.
J&J, which has been beset by recalls of more than 250 million bottles of its consumer health care medicines as well as other products due to manufacturing and quality control problems, has stepped up inspections at plants across its business.
"There is no issue with the Simponi drug product. It is merely the drug delivery device that has a manufacturing issue," Monica Neufang, a business communications spokeswoman for J&J, said of the latest recall.
From the affected US lot of 839 pre-filled injection devices, nearly 80 percent were quarantined at the wholesaler level, the company said.
(Reuters)
The potential defect was discovered by the company during regular quality testing and the voluntary recall was initiated earlier this week.
J&J, which has been beset by recalls of more than 250 million bottles of its consumer health care medicines as well as other products due to manufacturing and quality control problems, has stepped up inspections at plants across its business.
"There is no issue with the Simponi drug product. It is merely the drug delivery device that has a manufacturing issue," Monica Neufang, a business communications spokeswoman for J&J, said of the latest recall.
From the affected US lot of 839 pre-filled injection devices, nearly 80 percent were quarantined at the wholesaler level, the company said.
(Reuters)
- About Us
- |
- Terms of Use
- |
-
RSS
- |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 沪ICP证:沪ICP备05050403号-1
- |
- 互联网新闻信息服务许可证:31120180004
- |
- 网络视听许可证:0909346
- |
- 广播电视节目制作许可证:沪字第354号
- |
- 增值电信业务经营许可证:沪B2-20120012
Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.